Mark A. M. Brouwers
Papers
1
Total Citations
84
H-Index
1
About
Mark A. M. Brouwers is a leading colorectal surgeon and researcher whose work has fundamentally advanced the safety and precision of minimally invasive colorectal surgery. His primary research areas encompass surgical oncology, intraoperative imaging, and the prevention of postoperative complications. Brouwers is best known for spearheading the landmark AVOID trial, a multicentre, randomised, controlled, phase 3 study published in 2024 that demonstrated how indocyanine green near-infrared fluorescence imaging for bowel perfusion assessment can significantly reduce the risk of anastomotic leakage—a devastating complication. This work, already cited 84 times, has provided the highest level of evidence for a technique that is rapidly becoming standard of care. Beyond this pivotal trial, his contributions include optimizing fluorescence-guided surgery protocols and improving patient outcomes through evidence-based innovation. With a career dedicated to translating cutting-edge imaging technology into tangible clinical benefits, Brouwers has established himself as a key figure in modern colorectal surgery, directly influencing how surgeons assess tissue viability and ultimately saving patients from life-threatening complications.
Research Focus
Key Achievements
Top Papers
- 1